Clinical Trials on Hormone-receptors Positive Breast Cancer in Netherlands
Total 532 results
-
Leiden University Medical CenterThe Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaboratorsSuspendedHER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response RateNetherlands
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Amsterdam UMC, location VUmcNovartis; Borstkanker Onderzoek GroepUnknownMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastNetherlands
-
Eli Lilly and CompanyCompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive TumorUnited States, Canada, Korea, Republic of, Italy, Austria, Belgium, Germany, Netherlands, Spain, Taiwan
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
The Netherlands Cancer InstituteCompletedBreast Cancer | Ovarian Cancer | Advanced CancerNetherlands
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
University Medical Center GroningenActive, not recruiting
-
Academisch Ziekenhuis MaastrichtEli Lilly and Company; Novartis; Pfizer; Gilead Sciences; Roche Pharma AG; AstraZeneca and other collaboratorsRecruitingAdvanced Breast Cancer | Metastatic Breast CancerNetherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingMetastatic Breast CancerNetherlands
-
University Medical Center GroningenCompletedMetastatic Breast CancerNetherlands
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterUMC Utrecht; Erasmus Medical Center; University of Sydney; Lunit Inc.; Dutch Breast... and other collaboratorsEnrolling by invitationBreast Cancer ScreeningNetherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
University Medical Center GroningenTerminatedLobular Metastatic Breast CancerNetherlands
-
University Medical Center GroningenMartini Hospital GroningenRecruitingBreast Cancer | Breast Cancer InvasiveNetherlands
-
University Medical Center GroningenCompleted
-
The Netherlands Cancer InstituteRoche Pharma AGCompletedBreast Cancer | Ovarian Cancer | Cervix Cancer | Endometrial CancerNetherlands
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
The Netherlands Cancer InstituteDutch Cancer SocietyCompletedBreast Cancer Survivors | Climacteric SymptomsNetherlands
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Zuyderland Medisch CentrumHologic, Inc.RecruitingBreast Cancer | Breast Neoplasms | Breast Cancer FemaleNetherlands
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
The Netherlands Cancer InstituteDutch Cancer Society; Pink Ribbon Inc.CompletedSexual Dysfunction | Breast Cancer Survivors | Intimacy ProblemsNetherlands
-
University Medical Center GroningenCompleted
-
Nij Smellinghe HosptialCompletedLymphedema | Breast Cancer Stage II | Early Disease OnsetNetherlands
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
UMC UtrechtCenter for Translational Molecular Medicine; Dutch Cancer Society; Vrienden UMC...RecruitingBreast Cancer | Breast Neoplasms | Metastatic Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Invasive Ductal Breast Cancer | Invasive Ductal Carcinoma of Female Breast | Adenocarcinoma BreastNetherlands
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
University Medical Center GroningenTechnical University of Munich; The Netherlands Cancer Institute; Institut de...CompletedBreast Cancer Female | Cardiac Complications | Acute Coronary EventsNetherlands
-
UMC UtrechtKarolinska Institutet; German Cancer Research Center; University Hospital Heidelberg and other collaboratorsActive, not recruitingMetastatic Breast CancerNetherlands
-
Erasmus Medical CenterRecruitingER+ Breast CancerNetherlands
-
Leiden University Medical CenterCompletedBreast Cancer | Ovarian Cancer | Neoplasm MalignantNetherlands
-
The Netherlands Cancer InstituteTerminated
-
The Netherlands Cancer InstituteRecruitingBreast Cancer Patients Undergoing Mastectomy With Immediate ReconstructionNetherlands
-
Erasmus Medical CenterUniversity Medical Center Groningen; Leiden University Medical CenterRecruitingAdvanced Breast CancerNetherlands
-
University Medical Center GroningenCompleted
-
UMC UtrechtInstitut National de la Santé Et de la Recherche Médicale, France; Philips... and other collaboratorsCompleted
-
Borstkanker Onderzoek GroepSanofi; Novartis; Amgen; Dutch Cancer SocietyCompleted
-
University Medical Center GroningenMartini Hospital GroningenCompleted
-
University Medical Center GroningenCompleted
-
UMC UtrechtNational Institute for Public Health and the Environment (RIVM); Dutch Cancer...CompletedBreast CancerNetherlands